These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17086054)

  • 1. Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity.
    Peng B; Voltan R; Cristillo AD; Alvord WG; Davis-Warren A; Zhou Q; Murthy KK; Robert-Guroff M
    AIDS; 2006 Nov; 20(17):2149-57. PubMed ID: 17086054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.
    Patterson LJ; Malkevitch N; Zhao J; Peng B; Robert-Guroff M
    DNA Cell Biol; 2002 Sep; 21(9):627-35. PubMed ID: 12396605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
    Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
    Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
    Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
    Cosma A; Nagaraj R; Bühler S; Hinkula J; Busch DH; Sutter G; Goebel FD; Erfle V
    Vaccine; 2003 Dec; 22(1):21-9. PubMed ID: 14604567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.
    Peng B; Wang LR; Gómez-Román VR; Davis-Warren A; Montefiori DC; Kalyanaraman VS; Venzon D; Zhao J; Kan E; Rowell TJ; Murthy KK; Srivastava I; Barnett SW; Robert-Guroff M
    J Virol; 2005 Aug; 79(16):10200-9. PubMed ID: 16051813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice.
    Liang X; Fu TM; Xie H; Emini EA; Shiver JW
    Vaccine; 2002 Sep; 20(27-28):3413-21. PubMed ID: 12213412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients.
    Silvestris F; Camarda G; Del Prete A; Tucci M; Dammacco F
    Eur J Clin Invest; 1999 Nov; 29(11):980-91. PubMed ID: 10583444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
    J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal antigens for HIV vaccines based on CD8+ T response, protein length, and sequence variability.
    Betts MR; Yusim K; Koup RA
    DNA Cell Biol; 2002 Sep; 21(9):665-70. PubMed ID: 12396609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells.
    Greenway AL; McPhee DA; Grgacic E; Hewish D; Lucantoni A; Macreadie I; Azad A
    Virology; 1994 Jan; 198(1):245-56. PubMed ID: 7903128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells.
    Ahmed Rahim MM; Chrobak P; Priceputu E; Hanna Z; Jolicoeur P
    Virology; 2013 Apr; 438(2):84-97. PubMed ID: 23433958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity.
    Asefa B; Korokhov N; Lemiale F
    Vaccine; 2010 Apr; 28(20):3617-24. PubMed ID: 20051277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.